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Abstract Three variants of the 57.5 kDa human plasma proteinase inhibitor antithrombin, HlQ, H65C, and Hl20C, have been expressed in baby 
hamster kidney cells to permit assignment of the ‘H NMR resonances from the three histidines and evaluation of the role of these histidines in heparin 
binding. The NMR assignments have enabled more definitive interpretation of previous NMR-based studies of human antithrombin to be made. 
Although resonances of all three histidines are perturbed by heparin binding, only histidine 120 plays a significant role in the heparin binding site. 
The perturbations of resonances from histidines 1 and 65 indicate proximity to the heparin binding site and consequent sensitivity to the presence 
of heparin. 
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1. Introduction 
Antithrombin is a member of the serpin superfamily of pro- 
teins, which are high molecular weight inhibitors of serine pro- 
teinases that appear to undergo a major conformational change 
as a necessary part of the inhibition mechanism [ 11. In addition, 
antithrombin is allosterically activated as an inhibitor of the 
blood coagulation proteinase factor X, by the negatively 
charged polysaccharide heparin [2] through transmission of a 
conformational change to the reactive center Pl residue [3]. As 
a means of investigating the conformational changes that can 
occur in antithrombin, we have previously used ‘H NMR spec- 
troscopy as a sensitive monitor of structural alterations [4-81. 
Given the large size of antithrombin (57.5 kDa based on amino 
acid [9] and carbohydrate sequences [lo]) we have been limited 
to one-dimensional NMR studies, but have made extensive use 
of NMR difference spectroscopy and examination of the imi- 
dazole resonances from the histidine residues, since these are 
extremely sensitive to environmental changes. Three of the five 
histidines in human antithrombin are significantly perturbed by 
heparin binding, with the pK, of one histidine being increased 
by 0.32 pH units [4]. From consideration of the structure of 
native and cleaved antithrombins, we think that these are his- 
tidines 1, 65 and 120 [1 l-131. However, interpretation of the 
one-dimensional NMR spectra in terms of specific structural 
alterations has been hampered by the lack of assignments for 
the histidine resonances. We describe here the preparation and 
characterization of histidine variants HlQ, H65C, and H120C, 
assignment of the NMR resonances from these three histidines, 
and interpretation of our earlier NMR data in light of these 
assignments. 
2. Materials and methods 
2.1. Site-directed mutagenesis and expression of recombinant human 
antithrombin 
Mutagenesis was carried out on human antithrombin cDNA sub- 
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cloned into mp19 Ml3 as described previously [3]. The antisense ol- 
igonucleotides used for the changes were S’CAC AGG GCT CCC TTG 
ACA GGT CAC GCA3’, 5’T GGA ATC TGC CAG GCA CTG ATA 
GAA AGT GG3’, and 5’T GGC AAA GAA GCA m CTG ATC 
AGA TG3’ for the HlQ, H65C, and Hl20C mutations, respectively, 
in which the underlined triplet corresponds to the changed amino acid. 
Since it was considered possible that the alteration at position 120 
would reduce the heparin affinity, thereby making protein isolation 
from heparin-Sepharose more difficult, antithrombin cDNA contain- 
ing a second mutation, Nl35Q, was used as the starting template for 
preparation of the Hl20C variant. This results in the absence of carbo- 
hydrate from position 135 and a consequent increase in heparin affinity. 
However, the effects of this mutation have been well characterized in 
wild-type antithrombin, which thus permits identification of the specific 
contribution of the H+C change at position 120 to be made [14,15]. 
For the H65C and HlQ mutations, wild-type antithrombin cDNA was 
used as the template. Following mutagenesis, the presence of the muta- 
tion was confirmed by sequencing. The antithrombin cDNA was ex- 
cised from Ml3 by digestion with San and XbaI and ligated into the 
expression vector pMAStop digested with the same restriction endonu- 
cleases. Stably transfected BHK cells were prepared as previously de- 
scribed, and selected for resistance to methotrexate and neomycin [16]. 
2.2. Isolation of antithrombins 
Recombinant antithrombin was isolated from serum-free growth me- 
dium of confluent BHK cells, and plasma antithrombin was isolated 
from pooled outdated human plasma, by heparin-Sepharose affinity 
chromatography, and, where necessary, by chromatography on G150 
and DEAE, as described [14]. Protein concentrations were determined 
‘.” spectrophotometrically using E280 nm = 0.65 [17] and a molecular weight 
of 57.5 kDa. Different glycoforrns of antithrombin are secreted by 
transfected BHK cells that differ in the type and extent of glycosylation 
and in affinity for heparin. The isoform designation of a particular 
fraction could be made from the mobility on SDS-PAGE and the lectin 
staining pattern [14]. 
2.3. Heparin-antithrombin dissociation constants 
Heparin binding to antithrombin was monitored by the change in 
endogenous protein tryptophan fluorescence, and the resulting data 
fitted by non-linear least squares analysis using the program MINSQ 
II (Micromath Scientific Software, Salt Lake City, UT) to obtain the 
dissociation constant. Fluorescence measurements were made on a 
SPEX spectrofluorimeter, exciting at 295 nm and observing tryptophan 
emission at 335 nm. The buffer used was 20 mM sodium phosphate at 
pH 7.4, containing 0.1 mM EDTA, 0.1% polyethylene glycol 8000 and 
0.1 M NaCl. 
2.4. Factor X, assay 
Rates of inhibition of factor X, by antithrombin species were meas- 
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ured by discontinuous pectrophotometric assay of residual proteinase 
activity under pseudo-first-order conditions using spectrozyme-X, 
chromogenic substrate. After incubation of antithrombin and factor X, 
for a given time the reaction was terminated by dilution into 100 PM 
spectrozyme_X, and residual factor X, activity determined by mono- 
toring the hydrolysis of substrate at 405 nm. Concentrations of factor 
X, and antithrombin of 20 nM and 1 PM, respectively, were used for 
all measurements. All measurements were carried out at 25°C in 20 mM 
sodium phosphate at pH 7.4, containing 0.1 mM EDTA, 0.1% poly- 
ethylene glycol 8000 and 0.1 M NaCl. 
2.5. NMR measurements 
‘H NMR spectra were recorded at 500 MHz on a Bruker AMXSOO 
spectrometer. A sweep width of 7500 Hz, pulse angle of 70”, and a 
selective low power solvent presaturation pulse of 0.5 s were employed. 
Each spectrum represents the average of 3000 scans. Samples were 
0.1-0.15 mM in 20 mM sodium phosphate buffer at pH 7.0 in D,O 
containing 150 mM NaCI, and were transferred to the D,O buffer by 
5 cycles of concentration and dilution in an Amicon ultrafiltration cell 
fitted with a PM30 membrane. pH 7.0 was chosen as a compromise 
between physiological pH for optimal stability and a very low pH to 
give the greatest separation of the histidine resonances. 
2.6. Materials 
Full-length high affinity heparin, M, 9,000, was a generous gift from 
Dr. Steven Olson; human factor X,, a generous gift from Dr. Paul Bock, 
Vanderbilt University, was prepared by affinity chromatography on 
soybean trypsin inhibitor-Sepharose [18]; plasmids pMAStop, 
pRMH140, and pSV2dhfr [16] were generous gifts from Dr. Gerd 
iettlmeiB1, Behringwerke, Marburg; 99.9 atom% D,O was from Sigma 
(St. Louis, MO); Spectrozyme-X, was from American Diagnostica 
(Greenwich, CT). 
3. Results 
Hl 
3.1. Assignment of histidine C(2) ‘H resonances 
The ‘H NMR spectrum of plasma antithrombin shows well- 
resolved signals from three of the five histidine residues in the 
protein (Fig. l), each of which is sensitive to heparin binding 
in both native and cleaved states, as shown by previous studies 
[4-61. The remaining two histidines give much broader reso- 
nances close to the central resonance [4]. Of the histidines in 
human antithrombin (at positions 1, 65, 120, 319, and 369) 
those at positions 319 and 369 are unlikely to give rise to the 
sharp heparin-sensitive resonances since these histidines are 
well removed from the heparin binding site, and heparin bind- 
ing to cleaved antithrombin, which does not cause a long-range 
change in conformation [19], still perturbs the three narrow 
resonances. In contrast, the X-ray structure of native an- 
tithrombin [13] shows that histidines 1, 65 and 120 are close to 
the proposed location of the heparin binding site and are there- 
fore likely to be sensitive to heparin binding in both native and 
cleaved states. 
Positive assignments of the C(2) ‘H resonances from histidi- 
nes 1 and 65 were made from their NMR spectra (Fig. 1 and 
Table 1), which showed that histidine 1 gives rise to the sharp- 
est, central, resonance at 7.89 ppm, whereas histidine 6.5 gives 
rise to the broader, more downfield resonance at 8.15 ppm. 
Unfortunately a positive assignment of the histidine 120 reso- 
nance could not be obtained since H120C antithrombin proved 
to be unstable at the relatively high concentrations needed for 
NMR spectroscopy. This variant had a strong tendency to 
aggregate and denature, as judged by precipitation of the sam- 
ple upon concentration in an Amicon ultrafiltration cell during 
transfer to D,O buffer, as well as by the NMR spectrum of the 
trace amount of antithrombin that remained in solution, which 
PPm 
Fig. 1. C(2) ‘H resonances from histidines 1,65 and 120 in the 500 MHz 
NMR spectrum of plasma and recombinant variant human antithrom- 
bins. (Top) Plasma antithrombin, with assignments indicated for the 
three histidines; (middle) H65C variant antithrombin, which lacks the 
resonance at 8.14 ppm from histidine 65; (bottom) HIQ variant an- 
tithrombin, which lacks the resonance at 7.89 ppm from histidine 1. 
had the appearance of a denatured form. This may be due to 
sulfide-&sulfide exchange between the newly incorporated cys- 
teine at position 120 and the nearby disulfide between cysteine 
8 and cysteine 128, or to a critical stabilizing role played by 
histidine 120. By a process of elimination the resonance at 7.73 
ppm was assigned to histidine 120. This assignment is entirely 
consistent with the properties of this histidine (see below). 
A similar instability has recently been reported for another 
heparin-binding site variant antithrombin, R129Q [20], which 
was predominantly in the conformationally altered locked con- 
formation [21,22] analogous to the latent form of plasminogen 
activator inhibitor 1[23]. Since the transition to the locked form 
involves insertion of the reactive center loop into /?-sheet A of 
antithrombin, this again suggests a structural linkage between 
the reactive center loop region and the heparin binding site of 
antithrombin, such as has been shown by other means [3,24]. 
3.2. Antithrombin-heparin dissociation constants 
Heparin-antithrombin dissociation constants were deter- 
mined for the form II glycoforms of HlQ and H65C variant 
antithrombins, which most closely resembles the dominant 
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Table 1 
NMR characterization of histidines 1, 65 and 120 
Hi&line Av% (Hz) o (ppm) Au (HAH)b da(psac@ &(cleaved)” pe dpe Effect of guanidine” 
1 3 1.89 + 0.042 + 0.031 + 0.041 5.93 + 0.07 Smooth change 
65 13 8.15 - 0.017 - 0.087 - 0.087 6.90 0 Opposite sign changes at low and 
high concns. 
120 15 7.73 + 0.091 + 0.018 + 0.028 5.13 + 0.32 Discontinuous change 
“Half height linewidth (AQ) and chemical shift (a) are from spectrum shown in Fig. 1, with a sample pH of 7.0. 
bChange in chemical shift (da) upon binding full-length heparin (HAH) or pentasaccharide atpH 6.5, taken from [7]. 
‘Change in chemical shift (da) at pH 6.35 upon cleavage of native antithrombin in the reactive center loop by thrombin, taken from [6]. 
dpK,, and change in pK, of histidine upon binding full-length, unfractionated, heparin, taken from [4]. 
’ Behavior of histidine C2 resonance upon titration with guanidine hydrochloride at low concentrations. The abrupt change reported for histidine 
120 occurs at a guanidine concentration of 0.6 M, with smooth changes below and above the transition. Taken from [5]. 
a plasma form in glycosylation pattern, and for the highest 
affinity isoform of H120C, which most closely resembles the 
minor plasma B form and wild-type recombinant isoform III. 
The heparin affinities of the HlQ and H65C variants were very 
similar to that of wild-type antithrombin, indicating that nei- 
ther histidine is directly involved in heparin binding (Table 2). 
In contrast, the affinity of the H120C variant was significantly 
reduced compared to wild-type isoform III, indicating that the 
histidine plays a role in heparin binding (Table 2). The weaken- 
ing in affinity corresponds to a MG of about 2.4 kcal.mol-‘. 
It should be noted that, at the low concentrations of H120C 
antithrombin used for these binding experiments, the protein 
behaves as a monomer, as judged by its elution position from 
a Sepharose G150 sizing column used in purification. 
3.3. Rate of inhibition of factor X, 
Rates of inhibition of factor X, by each of the three variant 
antithrombins were determined and were found to be very 
similar to those of wild-type and of plasma antithrombins 
(Table 2), indicating no structural defect in the reactive center 
region as a result of any of the amino acid substitutions. 
4. J%msion 
By making histidine substitution variants of human an- 
tithrombin it has been possible to make definitive assignments 
of the resonances from two of the three histidines the NMR 
signals of which are strongly perturbed by heparin binding, and 
a probable assignment of the third, and also to determine the 
importance of these residues in heparin binding and proteinase 
inhibition. Having made these assignments it was then possible 
Table 2 
Kinetic and thermodynamic properties of antithrombin species 
Antithrombin Ko (nM) AG (kcal.mol-‘) k,,, (mM_’ s-l)” 
HlQ 9f4 11.04 2.3 
H65C 5.5 + 1 11.34 4.2 
Wild-type form II 4.5 -I 1 11.45 2.6 
H120C 130 f 20 9.45 2.5 
Wild-type form III 2.3 11.85 3.6 
a Dissociation constant for antithrombin-high affinity heparin complex 
determined from the enhancement of endogenous tryptophan fluores- 
cence of antithrombin upon binding heparin. 
b Apparent second order rate constant for inhibition of factor X, by 
antithrombin, determined by discontinuous assay of residual factor X, 
activity. 
‘Determined by extrapolation from values determined at I 0.3,0.4 and 
0.5 [14]. 
to make a residue-specific attribution of previously observed 
properties of these histidine residues. This includes the pK, of 
each histidine in the absence and presence of heparin, the chem- 
ical shift perturbation of each histidine resonance upon binding 
different heparin species and upon cleavage of the reactive 
center peptide bond, and the behavior of these resonances upon 
addition of low concentrations of guanidine hydrochloride 
(Table 1). The properties and roles of each of the three histid- 
ines is discussed in turn. 
4.1. Histidine I 
Replacement of histidine 1 by the approximately isosteric 
glutamine resulted in no alteration in the affinity of antithrom- 
bin for heparin or of antithrombin’s ability to inhibit pro- 
teinase. The residue is thus not involved in either heparin bind- 
ing or proteinase inhibition. The very small change in pK, upon 
binding heparin (Table 1) is consistent with lack of involvement 
in heparin binding. However, this histidine senses binding of 
full-length and pentasaccharide high affinity heparin, and of 
lower affinity heparin species [4,7,8], as well as the conforma- 
tional change that occurs upon cleavage of the reactive center 
loop and insertion of the reactive center into B-sheet A, as 
judged by the change in chemical shift of the imidazole NMR 
resonances (Table 1). In cleaved antithrombin, the perturbation 
of the histidine 1 chemical shift upon binding heparin is about 
the same as in native antithrombin [6]. These properties uggest 
that histidine 1 is close to the principal region of the heparin 
binding site but is not in contact with the heparin chain. 
Other things being equal, an N-terminal histidine should 
have a lower pK, than that of an internal histidine residue. 
Based upon this expectation, we had tentatively identified the 
histidine with the pK, of 5.13 as histidine 1 [4]. We have now 
shown that this is incorrect and that histidine 1 has a pK, of 
5.93, which, though normal for an internal histidine, is abnor- 
mally high for an N-terminal histidine. This suggests that the 
imidazole side chain of histidine 1 or the free a-amino group 
is involved in an ionic interaction to account for the abnormally 
high pK,. Since the linewidth of the C(2) NMR resonance of 
this histidine is extremely narrow (Table l), indicating relatively 
unhindered rotation of the imidazole side chain, it is more likely 
that the terminal amino group is involved in an ionic interac- 
tion. It appears that this interaction is unaffected upon binding 
heparin or upon reactive center loop cleavage, as judged by the 
minimal changes in pK, and linewidth. 
The C2 resonance shows a smooth change in chemical shift 
upon addition of guanidine, resulting simply from ionic 
strength effects (Table 1). No discontinuity is seen, such as 
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occurs with histidine 120, suggesting that the guanidine-in- 
duced conformational change does not affect this histidine. 
4.2. Histidine 65 
As with histidine 1, this histidine appears not to be involved 
in heparin binding or proteinase inhibition, as judged by disso- 
ciation and inhibition rate constants and by the lack of pK, 
change upon binding heparin, but again has ‘H NMR reso- 
nances that are sensitive to heparin binding and to cleavage in 
the reactive center loop (Table 1). The location of this histidine 
on the A helix, the end of which abuts the proposed heparin 
binding site 1131, is consistent with this sensitivity to heparin 
binding without direct involvement in heparin binding. The 
sensitivity to cleavage in the reactive center loop suggests that 
the subsequent conformational change significantly affects the 
A helix, which is located a considerable distance from the reac- 
tive center loop. Guanidine has opposite effects on the C2 
resonance above and below 0.4 M (Table I), suggesting sensi- 
tivity to a guanidine-induced conformational change. 
4.3. Histidine 120 
Based on the reduction in affinity of antithrombin for hepa- 
rin upon replacement of histidine 120 by cysteine, which corre- 
sponds to a AAG of about 2.4 kcal.mol-‘, it appears that this 
histidine plays an important role either directly in binding to 
heparin or indirectly in maintaining the correct conformation 
of the heparin binding site. Since the pK, of this residue is very 
low in native antithrombin and is only raised by 0.32 pH units 
upon binding heparin, resulting in the imidazole side chain 
being unionized at physiological pH even in the heparin-an- 
tithrombin complex, it is unlikely that a charged interaction 
between histidine 120 and heparin occurs. In addition it has 
been shown that, although the chemical shift of this residue is 
markedly affected by full-length heparin, it is only slightly af- 
fected by high affinity pentasaccharide, suggesting that it is 
located at the end of the pentasaccharide binding site [7l. This 
implies a lack of direct involvement in binding the critical pen- 
tasaccharide heparin sequence. Since the difference in affinity 
of heparin pentasaccharide and full-length heparin corresponds 
to only a single additional ionic interaction [2], which is not 
likely to be supplied by histidine 120 for the reason given, the 
chemical shift and pK, perturbation of histidine 120 by full- 
length heparin is likely to be an indirect effect. This suggests 
that the role of histidine 120 in determining heparin affinity is 
to maintain a particular conformation for the heparin binding 
site. This is consistent with the effect that low concentrations 
of guanidine have on the histidine 120 resonance in native but 
not in cleaved antithrombin [5]. Thus in native antithrombin the 
structural transition that occurs upon addition of guanidine to 
0.6 M, which results in a reduction in heparin affinity and which 
is thought to involve partial insertion of the reactive center loop 
into B-sheet A, causes an abrupt change in the chemical shift 
of the histidine 120 resonance, indicating a linked change in the 
heparin binding site. In contrast, no such abrupt chemical shift 
change is seen upon adding guanidine to cleaved antithrombin. 
Since cleaved antithrombin already has the complete reactive 
center loop inserted into B-sheet A, no further structural tran- 
sition involving the reactive center loop is possible and conse- 
quently there can be no conformational change transmitted to 
the heparin binding region. 
To interpret the increase in pK, of histidine 120 upon binding 
heparin, it is first necessary to understand why the pK, of this 
histidine is depressed from that of a normal histidine. In the 
X-ray structure of cleaved bovine antithrombin, histidine 120 
appears to be on the outer face of the D helix, in close proximity 
to the positive charges of arginines 46 and 47 and lysine 125 
(human numbering) [l 11. These residues are all ones proposed 
to be involved in direct electrostatic interactions with heparin 
pentasaccharide. Thus the low pK, of histidine 120 probably 
arises from the cluster of nearby positive charges, and the 
increase in pK, upon heparin binding arises from the partial 
neutralization of these charges by interaction with the nega- 
tively charged heparin. 
4.4. Conclusion 
NMR studies on HlQ and H65C variant antithrombins have 
provided definitive assignments for two of the three heparin- 
perturbable histidines in antithrombin. The assignment of the 
histidine 120 resonance is more tentative, but consistent with 
the available data. Using the histidine resonance assignments, 
older NMR data have been interpreted more definitively. We 
concluded that the binding site of the high affinity heparin 
pentasaccharide ends close to histidine 120, and that this histid- 
ine is involved in maintaining the correct conformation of the 
heparin binding site but is not directly involved in binding 
heparin. Histidines 1 and 65 are close to, but not in, the heparin 
binding site and report on the binding of the highly charged 
heparin molecule. Both histidines 65 and 120 are sensitive to 
the guanidine-induced conformational change that is thought 
to involve the reactive center loop region. The instability of the 
H120C variant and the proposal that histidine 120 plays a role 
in maintaining the conformation of the heparin binding site are 
consistent with one another and reminiscent of a recent report 
on an arginine 129 variant of antithrombin which also showed 
instability [20]. 
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